Saroglitazar improves atherogenic risk in patients with nonalcoholic fatty liver disease: pooled analysis from randomized controlled trialsMohammad S. Siddiqui,Deven V. Parmar, Shiv K. Sarin,Laura Cisneros,Samer Gawrieh,Taufik Momin,Ajay K. Duseja,Arun J. SanyalHEPATOLOGY(2022)引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要